Results 321 to 330 of about 460,260 (336)

Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: A pilot study

Kidney International, 2004
Vincenzo Panichi, Francesca Boscaro
exaly  

ENZYME REPLACEMENT THERAPY IN MPS1

Neuropediatrics, 2006
L De Meirleir, A Benatar, A Van Hulle, G Van Berlaer   +3 more
openaire   +1 more source

Does early use of enzyme replacement therapy alter the natural history of mucopolysaccharidosis I? Experience in three siblings

Molecular Genetics and Metabolism, 2013
Catherine Breen, Jean Mercer, James E Wraith   +2 more
exaly  

Enzyme replacement therapy and beyond—in memoriam Roscoe O. Brady, M.D. (1923–2016)

Journal of Inherited Metabolic Disease, 2017
M. Ries
semanticscholar   +1 more source

Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age–a sibling control study

Clinical Genetics, 2010
David Coman, J J Hopwood
exaly  

Enzyme Replacement Therapy

2008
openaire   +1 more source

Assessment of stability, toxicity and immunogenicity of new polymeric nanoreactors for use in enzyme replacement therapy of MNGIE

Journal of Controlled Release, 2009
Jan Steyaert, Jo Van Ginderachter, Wim Versees   +2 more
exaly  

Hormone replacement therapy in cancer survivors: a con opinion

Ca-A Cancer Journal for Clinicians, 1996
Carolyn D Runowicz
exaly  

Hormone-replacement therapy and the risk of breast cancer

Ca-A Cancer Journal for Clinicians, 1990
exaly  

The first 5years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I

Expert Opinion on Pharmacotherapy, 2005
J E Wraith
exaly